depression from semaglutide Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database GLP-1 diabetes drugs could stop
Description
There is also an individual patient response
At week 52, the estimated median ratio to baseline in maximum walking distance was 1.21 in the semaglutide group compared to 1.08 in the placebo group
(Jan 4, 2026) Psychiatrists perspective on metabolic psychiatry and GLP-1 integration
The New York Times
I then turned 65 yrs old and that is the age I had to switch to Tricare for life, with Medicare A and B which now TFL doesnt cover my Zepbound anymore
